% Expired Patents = 40.0

Forward Citations = 25

Loading Chart...

7 inventors (with patents filed for the assignee):

Martin Joseph Cummins (4 out of 4 patents)

Chau-Ting Yeh (3 out of 4 patents)

Ching-Yuan Lee (3 out of 3 patents)

4. Philip C Fox (1 out of 2 patents)

5. Joseph M Cummins (1 out of 17 patents)

6. Alan B Richards (1 out of 1 patent)

7. Edward Sherwood (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 9839672 - Treatment of thrombocytopenia using orally administered interferon (2017-12-12),

2. 9750786 - Treatment of thrombocytopenia using orally administered interferon (2017-09-05),

3. 9526694 - Treatment of thrombocytopenia using orally administered interferon (2016-12-27),

4. 6656920 - Composition and method for promoting oral health (2003-12-02),

5. 6036949 - Treatment of fibromyalgia with low doses of interferon (2000-03-14),

Company Overview

Amarillo Biosciences, Inc. is a biotechnology company focused on developing therapeutic products for autoimmune diseases, cancer, and viral infections. Our innovative approach combines cutting-edge research with a commitment to improving patient outcomes. With a strong pipeline of potential treatments, we strive to make a positive impact on global health through our groundbreaking biotech solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#10 in Amarillo, TX

#3,330 in Texas

#51,570 in US

Amarillo, TX, United States of America

Amarillo Biosciences, Inc.

Forward Citations = 25

7 inventors:

Martin Joseph Cummins (4 out of 4 patents)

Chau-Ting Yeh (3 out of 4 patents)

Ching-Yuan Lee (3 out of 3 patents)

4. Philip C Fox (1 out of 2 patents)

5. Joseph M Cummins (1 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amarillo Biosciences, Inc.. Retrieved from https://idiyas.com/company/amarillo-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]